Chougnet, Cecile N <br/><br/>
Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort.  [electronic resource] 

 -  Thyroid : official journal of the American Thyroid Association  Apr 2015 
 - 386-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1557-9077 
<br/><br/><label>Standard No.: </label>10.1089/thy.2014.0361  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Neuroendocrine--drug therapy<br/>Child<br/>Female<br/>France<br/>Humans<br/>Male<br/>Middle Aged<br/>Piperidines--adverse effects<br/>Protein Kinase Inhibitors--adverse effects<br/>Quinazolines--adverse effects<br/>Retrospective Studies<br/>Risk Factors<br/>Thyroid Neoplasms--drug therapy<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult